A Phase 3 study of VX-993 for diabetic neuropathy pain

Recruiting Phase 2 NCT06619860

Study Description

Evaluating the effectiveness and safety of VX-993 for pain relief in people with diabetic nerve pain

Study Details

Registry ID:: NCT06619860
Conditions:: Diabetic Peripheral Neuropathic Pain
Phase:: Phase 2
Target Enrollment:: 300 participants
Start Date:: October 18, 2024
Age Range:: 18–80 years
Healthy Volunteers:: No

Study Locations (49 sites)

CHU de Nîmes - Pain Assessment and Treatment Center
NimesFrance, France
IRCCS Ospedale San Raffaele - InSpe and Division of Neuroscience
MilanItaly, Italy
North Hospital
Saint-Priest-en-JarezFrance, France
North Hospital
St Priest en JarezFrance, France
Centre Hospitalier Universitaire (CHU) de Saint-Etienne - Hopital Nord
St Priest en JarezFrance, France
Centre Hospitalier Universitaire de Clermont Ferrand
Clermont FerrandFrance, France
Centre Hospitalier Universitaire de Clermont-Ferrand - Site Gabriel-Montpied
Clermont-FerrandFrance, France
Centre Hospitalier Universitaire de Clermont Ferrand
Clermont-FerrandFrance, France
Fondazione IRCCS Istituto Neurologico Carlo Besta
MilanItaly, Italy
Hôpital Cochin - Centre d'Evaluation et de Traitement de la Douleur (CETD)
ParisFrance, France
Hopital Cochin - Rheumatology
ParisFrance, France
FutureMeds Frankfurt
Offenbach/MainGermany, Germany
St Pancras Clinical Research
LondonUnited Kingdom, United Kingdom
Birmingham Heartlands Hospital - Heartlands Hospital Diabetes Centre and MIDRU
BirminghamUnited Kingdom, United Kingdom
FutureMeds Birmingham
BirminghamUnited Kingdom, United Kingdom
George Eliot Hospital NHS Trust - Diabetes and Endocrinology Centre
NuneatonUnited Kingdom, United Kingdom
George Eliot Hospital NHS Trust
NuneatonUnited Kingdom, United Kingdom
Ruhr-Universitaet Bochum - Heart and Diabetes Center
Bad OeynhausenGermany, Germany
Royal Hallamshire Hospital - Endocrinology
SheffieldUnited Kingdom, United Kingdom
Aintree University Hospital
LiverpoolUnited Kingdom, United Kingdom
University of Liverpool - Aintree University Hospital
LiverpoolUnited Kingdom, United Kingdom
Manchester Diabetes Centre (MDC)
ManchesterUnited Kingdom, United Kingdom
CHU de Nîmes
NimesUnited Kingdom, United Kingdom
emovis GmbH
BerlinGermany, Germany
FutureMeds GmbH
BerlinGermany, Germany
FutureMeds Glasgow
GlasgowUnited Kingdom, United Kingdom
Ninewells Hospital
DundeeUnited Kingdom, United Kingdom
Ninewells Hospital - Endocrinology
DundeeUnited Kingdom, United Kingdom
Suncoast Research Associates
Miami, FloridaUnited States, United States
Velocity Clinical Research - Hallandale Beach
Hallandale Beach, FloridaUnited States, United States
Innovation Medical Research Center
Palmetto Bay, FloridaUnited States, United States
Health Awareness
Jupiter, FloridaUnited States, United States
Health Awareness - PSL
Port Saint Lucie, FloridaUnited States, United States
Accel Research Site - Deland Clinical Research Unit
DeLand, FloridaUnited States, United States
Eximia Clinical Research - NC
Raleigh, North CarolinaUnited States, United States
Altasciences Montreal
MontrealCanada, Canada
Altasciences - Beaumont Clinic Montreal
MontrealCanada, Canada
Clinical Trials of South Carolina - Berkeley
Moncks Corner, South CarolinaUnited States, United States
Mount Sinai Hospital - Leadership Sinai Centre for Diabetes (LSCD)
TorontoCanada, Canada
ARSN - NeuroStudies
Decatur, GeorgiaUnited States, United States
Centricity Research Brampton
BramptonCanada, Canada
LMC Clinical Research Inc. d.b.a. Centricity Research
BramptonCanada, Canada
Healthcare Research Network II, LLC
Flossmoor, IllinoisUnited States, United States
Healthcare Research Network
Hazelwood, MissouriUnited States, United States
Eximia Research-CA, LLC
La Mesa, CaliforniaUnited States, United States
Trovare Clinical Research
Bakersfield, CaliforniaUnited States, United States
Velocity Clinical Research - Boise (Advanced Clinical Research)
Meridian, IdahoUnited States, United States
OCT Research ULC
KelownaCanada, Canada
Okanagan Clinical Trials
KelownaCanada, Canada

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →